Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism TEAD inhibitors(TEA domain transcription factors inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | South Korea | 28 Apr 2024 | |
Mesothelioma, Malignant | Preclinical | South Korea | 28 Apr 2024 |